MY GLP1 JOURNEY
Retatrutide 10mg Pen
Research-grade peptide pen acting as a triple-receptor agonist: GLP-1, GIP, and glucagon. Designed for advanced metabolic research—supports appetite control, glucose metabolism, and energy expenditure. For research use only.
FCFA 12,500
FCFA 12,500
Retatrutide 20mg Pen
Research-grade peptide pen, triple-receptor agonist for metabolic studies. For research use only. Not for human/veterinary consumption.
FCFA 17,500
FCFA 17,500
Retatrutide 30mg Pen
Research-grade peptide pen, triple-receptor agonist for appetite control, glucose metabolism and energy expenditure. Research use only.
FCFA 19,500
FCFA 19,500
Retatrutide 40mg Pen
Triple-receptor agonist peptide pen for metabolic research. Highest dosage Retatrutide. For research use only.
FCFA 27,500
FCFA 27,500
Mounjaro 2.5mg
Mounjaro 2.5mg/0.5ml. Dual GIP/GLP-1 receptor agonist for type 2 diabetes (off-label weight loss). Weekly injection. Starter dose. For research info.
FCFA 11,000
FCFA 11,000
Mounjaro 5mg
Mounjaro 5mg/0.5ml. Dual GIP/GLP-1 agonist, first standard therapeutic dose. Weekly injection. For research info.
FCFA 11,000
FCFA 11,000
Mounjaro 7.5mg
Mounjaro (tirzepatide) 7.5mg/0.5ml – advanced glycemic and weight control. Dual agonist for research and information.
FCFA 13,000
FCFA 13,000
Mounjaro 10mg
Mounjaro (tirzepatide) 10mg/0.5ml – high-dose research peptide, for aggressive glycemic control and weight loss studies.
FCFA 14,000
FCFA 14,000
Mounjaro 12.5mg
Mounjaro (tirzepatide) 12.5mg/0.5ml. Advanced research peptide for metabolic studies, aggressive glycemic control.
FCFA 15,000
FCFA 15,000
Mounjaro 15mg
Mounjaro (tirzepatide) 15mg/0.5ml – maximum dose research peptide for metabolic and weight loss studies.
FCFA 17,000
FCFA 17,000
